LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Inicio・Lista de Acciones・Novavax Inc

Novavax Inc

Cerrado

SectorSanidad

9.07 -3.1

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

8.93

Máximo

9.36

Métricas clave
By Trading Economics
Ingresos	-27M -9.5M
Ventas	-7.6M 140M
P/B Media del Sector	3.112 51.415
BPA	-0.06
Margen de beneficios	-6.803
Empleados	749
EBITDA	-44M -15M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+24.06% upside

Dividendos
By Dow Jones
Próximas Ganancias	5 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	242M 1.6B
Apertura anterior	12.17
Cierre anterior	9.07

Noticias sobre sentimiento de mercado

By Acuity

50%

155 / 345 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

5.692 / 6.039 Soporte y Resistencia

Novavax Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 may 2025, 14:30 UTC

Principales Noticias

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19 may 2025, 13:27 UTC

Principales Noticias

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

Comparación entre iguales

Cambio de precio

Novavax Inc previsión

Precio Objetivo

By TipRanks

24.06% repunte

Estimación a 12 Meses

Media 11.6 USD 24.06%

Máximo 18 USD

Mínimo 7 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novavax Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Novavax Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

5.692 / 6.039Soporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bearish.

Bearish events outweigh bullish events.

Sentimiento

By Acuity

155 / 345 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.